Similar articles for PMID: 23775618

Year	Number of Results
1989	1
1991	3
1992	1
1993	2
1994	4
1995	2
1996	2
1997	5
1999	2
2000	3
2001	2
2002	5
2003	6
2004	3
2005	1
2006	2
2007	1
2008	1
2009	3
2010	4
2011	5
2012	2
2013	6
2014	2
2015	3
2016	7
2017	5
2018	1
2019	4
2020	4
2021	1
2024	0

1

International consortium unveils numerous new cancer genetic markers.

Alvarez A. Alvarez A. CMAJ. 2013 Aug 6;185(11):E523. doi: 10.1503/cmaj.109-4467. Epub 2013 Jun 17. CMAJ. 2013. PMID: 23775618 Free PMC article. No abstract available.

2

BARD1, a possible biomarker for breast and ovarian cancer.

Irminger-Finger I. Irminger-Finger I. Gynecol Oncol. 2010 May;117(2):211-5. doi: 10.1016/j.ygyno.2009.10.079. Epub 2009 Dec 2. Gynecol Oncol. 2010. PMID: 19959210 Review.

3

Consolidated BRCA1/2 Variant Interpretation by MH BRCA Correlates with Predicted PARP Inhibitor Efficacy Association by MH Guide.

Hirotsu Y, Schmidt-Edelkraut U, Nakagomi H, Sakamoto I, Hartenfeller M, Narang R, Soldatos TG, Kaduthanam S, Wang X, Hettich S, Brock S, Jackson DB, Omata M. Hirotsu Y, et al. Int J Mol Sci. 2020 May 29;21(11):3895. doi: 10.3390/ijms21113895. Int J Mol Sci. 2020. PMID: 32486089 Free PMC article.

4

Prostate, Breast and Ovarian Cancer Genetic Risk Assessment: Connecting the Dots.

Gomella LG. Gomella LG. Can J Urol. 2016 Oct;23(5):8429. Can J Urol. 2016. PMID: 27705725 Free article. No abstract available.

5

Circulating tumor markers and nuclear medicine imaging modalities: breast, prostate and ovarian cancer.

Ugrinska A, Bombardieri E, Stokkel MP, Crippa F, Pauwels EK. Ugrinska A, et al. Q J Nucl Med. 2002 Jun;46(2):88-104. Q J Nucl Med. 2002. PMID: 12114872 Review.

6

[Novel preclinical models and biomarkers for prostate cancer].

Korzeniewski N, Tapia-Laliena M, Tolstov Y, Pahernik S, Hadaschik B, Hohenfellner M, Duensing S. Korzeniewski N, et al. Urologe A. 2013 Sep;52(9):1256-60. doi: 10.1007/s00120-013-3310-6. Urologe A. 2013. PMID: 23942741 Review. German.

7

Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study.

Dimitrakopoulou VI, Tsilidis KK, Haycock PC, Dimou NL, Al-Dabhani K, Martin RM, Lewis SJ, Gunter MJ, Mondul A, Shui IM, Theodoratou E, Nimptsch K, Lindström S, Albanes D, Kühn T, Key TJ, Travis RC, Vimaleswaran KS; GECCO Consortium; PRACTICAL Consortium; GAME-ON Network (CORECT, DRIVE, ELLIPSE, FOCI-OCAC, TRICL-ILCCO); Kraft P, Pierce BL, Schildkraut JM. Dimitrakopoulou VI, et al. BMJ. 2017 Oct 31;359:j4761. doi: 10.1136/bmj.j4761. BMJ. 2017. PMID: 29089348 Free PMC article.

8

Evaluation of TATI and other markers in solid tumors.

Taccone W, Mazzon W, Belli M. Taccone W, et al. Scand J Clin Lab Invest Suppl. 1991;207:25-32. doi: 10.3109/00365519109104622. Scand J Clin Lab Invest Suppl. 1991. PMID: 1780686

9

iCOGS collection provides a collaborative model. Foreword.

Bahcall OG. Bahcall OG. Nat Genet. 2013 Apr;45(4):343. doi: 10.1038/ng.2592. Nat Genet. 2013. PMID: 23535721 No abstract available.

10

Integrative genomic data mining for discovery of potential blood-borne biomarkers for early diagnosis of cancer.

Yang Y, Pospisil P, Iyer LK, Adelstein SJ, Kassis AI. Yang Y, et al. PLoS One. 2008;3(11):e3661. doi: 10.1371/journal.pone.0003661. Epub 2008 Nov 6. PLoS One. 2008. PMID: 18987750 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

88 results

Results by year